Acquiring Company
Black Hawk Acquisition
Acquired Company
Vesicor Therapeutics Holdings
Description
Black Hawk Acquisition Corporation has closed its business combination with Vesicor Therapeutics, announced on November 20, 2026. The transaction was approved by Black Hawk shareholders on October 13, 2026 and closed on November 19, 2026, with the combined company renamed Vesicor Therapeutics Holdings, Inc. Its common stock is expected to begin trading on Nasdaq under the ticker VESI on November 23, 2026.
Quick answer
Black Hawk Acquisition is acquiring Vesicor Therapeutics Holdings, announced November 19, 2026. Black Hawk Acquisition is based in Danville, California, United States.
- How much did Black Hawk Acquisition pay for Vesicor Therapeutics Holdings?
- The deal value was not disclosed.
- What does Black Hawk Acquisition do?
- Black Hawk Acquisition Corp is a special purpose acquisition company (SPAC) focused on acquiring and merging with high-potential businesses.
- Where are Black Hawk Acquisition and Vesicor Therapeutics Holdings based?
- Black Hawk Acquisition is based in Danville, California, United States. Vesicor Therapeutics Holdings is based in San Gabriel, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Vesicor completes Black Hawk business combination (November 19, 2026)
- Everis Medical combines with Hemostasis (November 17, 2026)
- Sai Parenterals to acquire Bion's Rx unit (November 17, 2026)
- Astromech acquires Form Bio for $230 million, $230M (November 17, 2026)
- Gedeon Richter to acquire Mayne Pharma at $6.40/share (November 16, 2026)
- Wolfram in talks to acquire Ellipses Pharma (November 16, 2026)
Who to call at Black Hawk Acquisition, and when
When Black Hawk Acquisition changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Black Hawk Acquisition raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Black Hawk Acquisition, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Black Hawk Acquisition. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Black Hawk Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Vesicor Therapeutics Holdings?
Vesicor Therapeutics Holdings was acquired by Black Hawk Acquisition, based in Danville. The deal was reported on November 19, 2026. Black Hawk Acquisition Corp is a special purpose acquisition company (SPAC) focused on acquiring and merging with high-potential businesses. The company is currently working on completing a business combination. Black Hawk Acquisition is publicly traded (BKHA) and operates in Biotechnology.
When did Black Hawk Acquisition acquire Vesicor Therapeutics Holdings?
Black Hawk Acquisition's acquisition of Vesicor Therapeutics Holdings was reported on November 19, 2026. Black Hawk Acquisition Corporation has closed its business combination with Vesicor Therapeutics, announced on November 20, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Vesicor Therapeutics Holdings do?
Vesicor Therapeutics Holdings, Inc. is an early development stage biotechnology company focused on p53-based cancer therapeutics delivered via precision-engineered microvesicles. It is privately held, operating in Biotechnology, and is based in San Gabriel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.